ASCLS eNewsBytes

• Sonomotion nabs FDA de novo clearance for Stone Clear device January 13, 2025
  The FDA has approved SonoMotion's Stone Clear device for anesthesia-free treatment of postlithotripsy kidney stone fragments. The device uses ultrasound pulses to move and facilitate passage of residual fragments without surgery, reducing the risk of complications and emergency department visits.
• Tularemia: The 'rabbit fever' that can fatally infect humans January 13, 2025
  Tularemia, also known as rabbit fever or deer fly fever, is a rare disease in the U.S., with 2,462 cases reported between 2011 and 2022. It is caused by Francisella tularensis bacteria, found in the Northern Hemisphere and occasionally in the tropics and Southern Hemisphere.
• Supplement use prevalent among individuals with COVID-19 in pandemic early years January 13, 2025
  Supplement consumption increased during the initial years of the COVID-19 pandemic for people testing positive for the virus, regardless of whether they were symptomatic.
• New brain stem cell discovery could usher in better treatments for glioblastoma January 13, 2025
  UCSF scientists have discovered a stem cell in the young brain capable of forming cells found in tumors, potentially explaining how adult brain cells instigate explosive growth in deadly brain cancers like glioblastoma.
• FDA has approved over 1,000 clinical AI applications, with most aimed at radiology January 13, 2025
  The U.S. Food and Drug Administration has approved numerous AI-enabled products, bringing the total number of cleared clinical applications to over 1,000. Radiology leads the list, accounting for over 70% of all clearances.